Antibodies against the multifaceted cathepsin D protein open new avenues for TNBC immunotherapy.

Saved in:
Bibliographic Details
Title: Antibodies against the multifaceted cathepsin D protein open new avenues for TNBC immunotherapy.
Authors: Desroys du Roure P; IRCM, INSERM U1194, University of Montpellier, ICM, Montpellier, France., David T; IRCM, INSERM U1194, University of Montpellier, ICM, Montpellier, France., Mallavialle A; IRCM, INSERM U1194, University of Montpellier, ICM, Montpellier, France., Laurent-Matha V; IRCM, INSERM U1194, University of Montpellier, ICM, Montpellier, France., Roger P; Department of Pathology, CHU Nîmes, Nîmes, France., Guiu S; Department of Medical Oncology, ICM, Montpellier, France., Chardès T; IRCM, INSERM U1194, University of Montpellier, ICM, Montpellier, France.; CNRS, Centre National de la Recherche Scientifique, Paris, F-75016, France., Liaudet-Coopman E; IRCM, INSERM U1194, University of Montpellier, ICM, Montpellier, France emmanuelle.liaudet-coopman@inserm.fr.
Source: Journal for immunotherapy of cancer [J Immunother Cancer] 2025 Jan 11; Vol. 13 (1). Date of Electronic Publication: 2025 Jan 11.
Publication Type: Journal Article
Journal Info: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Electronic Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2051-1426
DOI:10.1136/jitc-2024-009548